Journal article · 2026 · Open access

A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment

Jonathan Lettner, Marko Ostojić, Aleksandra Królikowska, Mahmut Enes Kayaalp, Nikolai Ramadanov, Robert Prill

Advances in Clinical and Experimental Medicine, 35(8), 1445–1453 · Published 9 April 2026 · DOI 10.17219/acem/216070

Open PDFView at the publisherCite this paper

In brief

“A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment” is a 2026 journal article by Jonathan Lettner and 5 co-authors, published in Advances in Clinical and Experimental Medicine. OpenAlex counts 2 citations as of 19 November 2026, which puts it in the top 6% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Advances in Clinical and Experimental Medicine.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
3.06
References
36
Authors
6

Abstract

BACKGROUND: Risk-of-bias (RoB) assessment is essential for evidence synthesis but remains time-consuming and inherently subjective. Artificial intelligence (AI) may improve the efficiency of systematic reviews; however, its reliability in reproducing expert RoB judgements remains uncertain. OBJECTIVES: To compare the performance of AI models and human raters in RoB assessment of randomized controlled trials (RCTs) using the revised Joanna Briggs Institute (JBI) critical appraisal tool. MATERIAL AND METHODS: Thirteen RCTs published between 2023 and 2025 in orthopedic journals were independently assessed by 2 human raters (an expert (R1) and a novice (R2)) and 2 AI models (ChatGPT-4.0 (CGPT) and DeepSeek-R1 (DS)) using the 13-domain JBI checklist. Deep-reasoning functionalities (e.g., chain-of-thought prompting) were applied. Inter-rater agreement, deviations from the expert assessment (reference standard), and binary disagreements (e.g., Yes vs No) were analyzed to evaluate consistency. RESULTS: The AI models demonstrated high inter-model agreement (91%), exceeding human-AI agreement (CGPT vs R1: 64%; DS vs R1: 68%). However, both AI systems showed substantial divergence from expert judgements in interpretive domains, including allocation concealment (Q2), blinding (Q7), and overall trial design (Q13), with deviation rates ranging from 30% to 38.5%. Binary decision reversals were more frequent in AI assessments (CGPT: 8.9%; DS: 7.7%) than in the human comparison (R2 vs R1: 2.4%). Human raters showed stronger agreement in contextual interpretation (R1-R2: 89.3%), whereas AI models performed better in rule-based domains (Q8/Q9: 100% agreement). CONCLUSIONS: AI can reliably support the automation of objective components of RoB assessment but remains limited in handling interpretive, context-dependent judgements. A hybrid approach combining AI-assisted pre-screening with expert evaluation may enhance the scalability of systematic reviews without compromising methodological rigor.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lettner, J., Ostojić, M., Królikowska, A., Kayaalp, M. E., Ramadanov, N., & Prill, R. (2026). A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment. Advances in Clinical and Experimental Medicine, 35(8), 1445–1453. https://doi.org/10.17219/acem/216070

MLA 9

Lettner, Jonathan, et al. “A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment.” Advances in Clinical and Experimental Medicine, vol. 35, no. 8, 2026, pp. 1445–1453. https://doi.org/10.17219/acem/216070.

Chicago

Lettner, Jonathan, Marko Ostojić, Aleksandra Królikowska, Mahmut Enes Kayaalp, Nikolai Ramadanov, and Robert Prill. 2026. “A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment.” Advances in Clinical and Experimental Medicine 35 (8): 1445–1453. https://doi.org/10.17219/acem/216070.

Harvard

Lettner, J. et al. (2026) ‘A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment’, Advances in Clinical and Experimental Medicine, 35(8), pp. 1445–1453. doi:10.17219/acem/216070.

IEEE

J. Lettner, M. Ostojić, A. Królikowska, M. E. Kayaalp, N. Ramadanov, and R. Prill, “A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment,” Advances in Clinical and Experimental Medicine, vol. 35, no. 8, pp. 1445–1453, 2026, doi: 10.17219/acem/216070.

BibTeX

@article{lettner2026peer,
  title     = {{A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment}},
  author    = {Lettner, Jonathan and Ostojić, Marko and Królikowska, Aleksandra and Kayaalp, Mahmut Enes and Ramadanov, Nikolai and Prill, Robert},
  journal   = {Advances in Clinical and Experimental Medicine},
  year      = {2026},
  volume    = {35},
  number    = {8},
  pages     = {1445--1453},
  doi       = {10.17219/acem/216070},
  url       = {https://doi.org/10.17219/acem/216070}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews

  • risk of bias assessment
  • artificial intelligence
  • ChatGPT
  • DeepSeek
  • human raters
  • randomized controlled trials
  • interobserver agreement
  • allocation concealment

Work with this paper

Most-cited papers in Decision Sciences

All highly cited Decision Sciences papers

Questions about this paper

How do I cite this paper in APA style?

Lettner, J., Ostojić, M., Królikowska, A., Kayaalp, M. E., Ramadanov, N., & Prill, R. (2026). A new peer reviewer? Comparing AI with human performance in randomized controlled trial risk-of-bias assessment. Advances in Clinical and Experimental Medicine, 35(8), 1445–1453. https://doi.org/10.17219/acem/216070

How many times has this paper been cited?

2 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advances in Clinical and Experimental Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Jonathan Lettner, Marko Ostojić, Aleksandra Królikowska, Mahmut Enes Kayaalp, Nikolai Ramadanov, Robert Prill.

What is the DOI of this paper?

10.17219/acem/216070, permanently at https://doi.org/10.17219/acem/216070. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.